Skip to content

Care Pathway for Patients With Fabry's Disease (Fabry-PATH)

Care Pathway for Patients With Fabry's Disease (Fabry-PATH)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07485660
Acronym
Fabry-PATH
Enrollment
200
Registered
2026-03-20
Start date
2026-04-01
Completion date
2026-11-01
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry Disease

Keywords

Fabry, Care pathway, Family screening, Symptoms, Comparison according to gender

Brief summary

Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, which could nevertheless impact diagnosis by identifying a profile of at-risk patients, and consequently, their management. The goal of this present study is to describe the differences in care pathways between men and women with Fabry's disease, distinguishing entry via symptoms or family screening through a non-interventional study based on a questionnaire sent to patients and on the collection of medical data at the time of diagnosis.

Interventions

Medical data of Fabry's disease

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient diagnosed with Fabry's disease

Exclusion criteria

* Minor patients

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic time in care pathways between men and women with Fabry's disease8 monthsThe average diagnostic time, compared between men and women, and the diagnostic methods (entry point into the disease), compared according to sex.
Comparison of diagnostic methods between men and women8 monthsData collection at the point of entry into the disease: via symptoms or family screening

Countries

France

Contacts

CONTACTOlivier LAIREZ
lairez.o@chu-toulouse.fr+33561323072

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026